Suppr超能文献

用于纤维肌痛的接纳与承诺疗法的疗效、可接受性及安全性——一项系统评价与荟萃分析

The efficacy, acceptability and safety of acceptance and commitment therapy for fibromyalgia - a systematic review and meta-analysis.

作者信息

Eastwood Florence, Godfrey Emma

机构信息

Department of Psychology, School of Mental Health & Psychological Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Mid and South Essex NHS Foundation Trust, Chelmsford, UK.

出版信息

Br J Pain. 2024 Jun;18(3):243-256. doi: 10.1177/20494637231221451. Epub 2023 Dec 12.

Abstract

BACKGROUND

Fibromyalgia (FM) is a chronic pain disorder characterised by widespread pain, fatigue and cognitive symptoms. Acceptance and commitment therapy (ACT) aims to improve psychological flexibility and has been found to be beneficial in treating chronic pain; however, there are few studies evaluating its efficacy in treating FM.

AIM

This systematic review and meta-analysis evaluated the efficacy of acceptance and commitment therapy in patients with fibromyalgia.

METHODS

PubMed, Embase and PsychInfo databases were searched. Randomised Controlled Trials (RCTs) were eligible for inclusion if participants had FM, and the intervention was based on the ACT framework/model, and not combined with any other active therapy; any non-ACT control was accepted. A meta-analysis was performed, with the primary outcomes pain acceptance (chronic pain acceptance questionnaire, CPAQ), health-related quality of life (fibromyalgia impact questionnaire, FIQ), attrition rate and frequency of adverse events, and the secondary outcomes pain intensity, disability, depression, anxiety, and fatigue.

RESULTS

Six RCTs, with a total of 384, mostly-female, participants were included, with ACT being delivered online, in a group setting, or one-to-one. ACT was superior to controls in improving FIQ score at post-intervention (SMD -1.05, 95% CI -2.02, -0.09) and follow-up (SMD -1.43, 95% CI -2.17, -0.69) and CPAQ post-intervention (SMD 1.05, 95% CI 0.61, 1.49) and at follow-up (SMD 0.95, 95% CI 0.40, 1.49). Attrition was below 20% in 4/6 studies and no adverse events were reported as attributable to ACT. All secondary outcomes showed large-to-moderate pooled effect estimates post-intervention, indicating improvement in anxiety, depression, pain and disability. Fatigue also improved, with a large negative effect.

CONCLUSIONS

The results suggest ACT improved outcomes in patients with FM: there was an overall improvement in all outcomes post-intervention, with most maintained at follow-up. This review was, however, limited by the small body of evidence and differing methodologies of included studies.

摘要

背景

纤维肌痛(FM)是一种慢性疼痛疾病,其特征为广泛疼痛、疲劳和认知症状。接纳与承诺疗法(ACT)旨在提高心理灵活性,已被发现对治疗慢性疼痛有益;然而,评估其治疗纤维肌痛疗效的研究较少。

目的

本系统评价和荟萃分析评估了接纳与承诺疗法对纤维肌痛患者的疗效。

方法

检索了PubMed、Embase和PsychInfo数据库。如果参与者患有纤维肌痛,且干预基于接纳与承诺疗法框架/模型,且未与任何其他积极疗法联合使用,则随机对照试验(RCT)符合纳入标准;接受任何非接纳与承诺疗法对照。进行了荟萃分析,主要结局为疼痛接纳(慢性疼痛接纳问卷,CPAQ)、健康相关生活质量(纤维肌痛影响问卷,FIQ)、失访率和不良事件发生率,次要结局为疼痛强度、残疾、抑郁、焦虑和疲劳。

结果

纳入了6项RCT,共384名参与者,大多数为女性,接纳与承诺疗法通过在线、小组或一对一方式提供。接纳与承诺疗法在干预后(标准化均数差 -1.05,95%可信区间 -2.02,-0.09)和随访时(标准化均数差 -1.43,95%可信区间 -2.17,-0.69)改善FIQ评分以及干预后(标准化均数差1.05,95%可信区间0.61,1.49)和随访时(标准化均数差0.95,95%可信区间0.40,1.49)改善CPAQ方面优于对照组。4/6项研究的失访率低于20%,未报告任何不良事件可归因于接纳与承诺疗法。所有次要结局在干预后均显示出大到中等程度的合并效应估计值,表明焦虑、抑郁、疼痛和残疾有所改善。疲劳也有所改善,有较大的负效应。

结论

结果表明接纳与承诺疗法改善了纤维肌痛患者的结局:干预后所有结局总体有所改善,大多数在随访时得以维持。然而,本综述受到证据量少和纳入研究方法不同的限制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ec/11092929/e35c5d9a7a85/10.1177_20494637231221451-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验